Lunai Bioworks Inc. (LNAI): Nasdaq/NYSE listing notice — Renovaro receives Nasdaq non-compliance notice for annual meeting; granted extension to Oct 31, 2025

Lunai Bioworks Inc.

Received Nasdaq notice on July 7, 2025 for failure to comply with Listing Rule 5620(a) requiring annual shareholder meeting.
Nasdaq accepted compliance plan on August 5, 2025 and granted extension until October 31, 2025 to hold meeting.
Company intends to hold annual meeting within the extension period to regain compliance with listing standards.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Lunai Bioworks Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: shareholders
Rules: 5620(a)

Exact text from the filing

July 7, 2025, Renovaro Inc. (the “Company”) received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5620(a), which requires listed companies to hold an annual meeting of shareholders within twelve months of the end of their fiscal year. On August 5, 2025, the Company received written confirmation from Nasdaq that it has accepted the Company’s plan to regain compliance and has granted an extension until October 31, 2025, for the Company to hold its annual meeting of shareholders. The Company intends to hold the ann

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Lunai Bioworks Inc. filing history →

Source: SEC EDGAR

accession 0001731122-25-001076

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.